Working… Menu

VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02436408
Recruitment Status : Active, not recruiting
First Posted : May 6, 2015
Last Update Posted : April 30, 2020
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center